New York, NY — November 4, 2015 — Media Alert
L.E.K. Consulting Managing Director Pierre Jacquet will moderate the "State of the Markets: Biotech and Pharma" panel discussion featuring: Tom Heyman, Janssen Pharmaceutica; Vivek Ramaswamy, Axovant; Ken Rice, BioAxone; Simos Simeonidis, RBC Capital; and Ron Squarer, Array BioPharma.
November 11, 2015
450 E 29th Street, New York, NY
10:40 — 11:10 a.m.
About Pierre Jacquet:
Pierre Jacquet is the Global Head of the Biopharmaceuticals & Life Sciences practice and a Managing Director and Partner in the Boston office. He is also a member of L.E.K.'s Global Leadership Team. Dr. Jacquet has more than 20 years of experience in corporate and business unit strategy consulting, R&D portfolio management and mergers and acquisitions advisory services. He has worked across many life science industry segments and has assisted clients with issues such as strategic opportunity evaluations, product prioritization, product planning and commercialization, strategic partnering, strategic activation and mergers and acquisitions.
Prior to joining L.E.K., he worked with Arthur D. Little as a manager of their pharmaceutical practice. Prior to consulting, Dr. Jacquet performed business development for Genzyme. He was also a Fellow at the Washington Cancer Institute, where he authored over 40 articles and book chapters about new chemotherapy regimens for gastrointestinal cancers. Dr. Jacquet received his Master of Business Administration from Darden Graduate School at the University of Virginia. He was also awarded a Doctorate of Philosophy (Ph.D.), summa cum laude, in Biomedical Sciences and a Doctor of Medicine, magna cum laude, from the University of Liège in Belgium. Prior Board directorships include Osprey Pharmaceuticals, T2C2 and Seaflower Venture.
About Boston Biotech Conferences:
The Boston Biotech Conferences (BBC) are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community.
About L.E.K. Consulting:
L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries — including the largest private and public sector organizations, private equity firms and emerging entrepreneurial businesses. Founded more than 30 years ago, L.E.K. employs more than 1,000 professionals across the Americas, Asia-Pacific and Europe. For more information, go to www.lek.com.